4 Einträge gefunden

1. Update Breast Cancer 2021 Part 2 - Advanced Stages, Long-Term Consequences and Biomarkers

   1. Ditsch, Nina
   2. Stickeler, Elmar
   3. Behrens, Annika
   4. Belleville, Erik
   5. Fasching, Peter A
   6. Fehm, Tanja N
   7. Hartkopf, Andreas D

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"

   1. Schneeweiss, Andreas
   2. Ettl, Johannes
   3. Lüftner, Diana
   4. Beckmann, Matthias W
   5. Belleville, Erik
   6. Fasching, Peter A
   7. Fehm, Tanja N

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Update Breast Cancer 2021 Part 1 - Prevention and Early Stages

   1. Stickeler, Elmar
   2. Aktas, Bahriye
   3. Behrens, Annika
   4. Belleville, Erik
   5. Ditsch, Nina
   6. Fasching, Peter A
   7. Fehm, Tanja N

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany

   1. Schneeweiss, Andreas
   2. Ettl, Johannes
   3. Lüftner, Diana
   4. Beckmann, Matthias W
   5. Belleville, Erik
   6. Fasching, Peter A
   7. Fehm, Tanja N

   2020 - Forschungsinformationssystem des UKE